| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Meeting Reports |
1 Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland; 2 DNA Measurements Group, Biochemical Science Division, National Institute of Standards and Technology, Gaithersburg, Maryland; 3 Lung Cancer Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico; and 4 Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Requests for reprints: Jacob Kagan, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Rockville, MD 20852. Phone: 301-496-9541; Fax: 301-402-8990; E-mail: kaganj{at}mail.nih.gov.
The workshop report, entitled Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint National Cancer Institute's Early Detection Research Network and National Institute of Standards and Technology Workshop, presents a summary of the main issues, current challenges, outcomes, and recommendations toward application of methylated DNA sequences as cancer biomarkers. [Cancer Res 2007;67(10):4545–9]
This article has been cited by other articles:
![]() |
A. R. Sepulveda, D. Jones, S. Ogino, W. Samowitz, M. L. Gulley, R. Edwards, V. Levenson, V. M. Pratt, B. Yang, K. Nafa, et al. CpG Methylation Analysis--Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology J. Mol. Diagn., July 1, 2009; 11(4): 266 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Punturieri, E. Szabo, T. L. Croxton, S. D. Shapiro, and S. M. Dubinett Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research J Natl Cancer Inst, April 15, 2009; 101(8): 554 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vlassenbroeck, S. Califice, A.-C. Diserens, E. Migliavacca, J. Straub, I. Di Stefano, F. Moreau, M.-F. Hamou, I. Renard, M. Delorenzi, et al. Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma J. Mol. Diagn., July 1, 2008; 10(4): 332 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Roy and J. D. Khandekar Biomarkers for the Early Detection of Cancer: An Inflammatory Concept Arch Intern Med, September 24, 2007; 167(17): 1822 - 1824. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |